S.A.L.F. S.p.A. Laboratorio Farmacologico

S.A.L.F. S.p.A. specializes in sterile intravenous solutions, including sodium chloride (0.9% and 12%) for hydration, apheresis, and infusion, as well as mannitol-sorbitol mixtures used in osmotic therapy. They also produce anticoagulant solutions like ACD-A, which are used for blood collection and preservation, and joint lubrication products under the Articulade brand. These products are designed for clinical use in hydration, blood processing, and joint care.

S.A.L.F. S.p.A. is based in Italy. Their devices are listed in the EUDAMED database, which is the European Union’s central registry for medical devices, ensuring transparency and traceability of products authorized under EU regulations.

The devices produced by S.A.L.F. S.p.A. fall into multiple risk-based classification categories under EU regulations: Class I (low-risk devices like some sterile solutions), Class IIa (moderate-risk devices such as certain anticoagulants), Class IIb (higher-risk devices like specialized infusion solutions), and Class III (high-risk devices, potentially including some joint lubrication products or critical anticoagulants). Classification depends on factors like intended use, duration of contact with the body, and potential risks.

Sodium chloride 0.9% solutions are primarily used for hydration, fluid replacement, and dilution of medications or blood products during infusion or apheresis procedures. The 12% sodium chloride is typically used in specific clinical scenarios requiring hypertonic solutions. Mannitol-sorbitol mixtures are osmotic diuretics, often administered intravenously to reduce intracranial or intraocular pressure or to promote diuresis in certain medical conditions.

Class III classification under EU regulations applies to devices that support or sustain life, are of significant risk, or have a critical function in treating or diagnosing life-threatening conditions. For S.A.L.F. S.p.A., this may include anticoagulant solutions like ACD-A, which are essential for blood preservation during procedures like transfusions or apheresis, as their improper use could pose severe risks to patient safety. Classification ensures rigorous scrutiny and compliance to mitigate these risks.